ACPA binds citrullinated structures and is quite specific for RA, whereas RF is an anti-antibody that builds immune complexes and is observed in a substantial proportion of patients with other inflammatory diseases and healthy controls. The gene discussed is PRTN3; the disease is rheumatoid arthritis.